Zhang_2004_Acta.Pharmacol.Sin_25_431

Reference

Title : Anti-epitope antibody, a novel site-directed antibody against human acetylcholinesterase - Zhang_2004_Acta.Pharmacol.Sin_25_431
Author(s) : Zhang XM , Liu G , Sun MJ
Ref : Acta Pharmacol Sin , 25 :431 , 2004
Abstract :

AIM: To construct synthetic antigens using the epitope of human brain acetylcholinesterase (hbAChE) for induction and detection of the specific antibody against the epitope, and to analyse the immunogenicity of the antibody.
METHODS: The epitope (RTVLVSMNYR, amino acids 143-152) of hbAChE was chemically synthesized, coupled with the carrier protein keyhole limpet hemocyanin (KLH) to construct an artificial immunogen (KLH-epitope), and injected into rabbits to raise antibody. The epitope conjugated with bovine serum albumin (BSA) was used as the detection antigen. The specificity of the antibody was tested by enzyme-linked immunosorbent assay (ELISA) and Western blotting. The immunoreaction between the anti-recombinant human butyrylcholinesterase (rhBChE) polyclonal antibody and the biotinylated-epitope was examined by indirect ELISA.
RESULTS: The erythrocyte AChE, the hbAChE, rhBChE and the BSA-epitope all immunoreacted with the anti-epitope antibody against the epitope (143-152) of hbAChE, whereas the torpedo AChE did not. CONCLUSION: The hbAChE, the human erythrocyte AChE and hBChE share the conservative antigenic epitope RTVLVSMNYR, hence they can all immunoreact with the anti-epitope antibody. Since the epitope of hbAChE is less similar with the aligned amino acid sequences of AChE of Torpedo californica or Torpedo marmorata, there is not any immunoreactivity between them. The R, M, and N residues in the epitope seem to be necessary radicals for the conservation of antigenicity.

PubMedSearch : Zhang_2004_Acta.Pharmacol.Sin_25_431
PubMedID: 15066208

Related information

Citations formats

Zhang XM, Liu G, Sun MJ (2004)
Anti-epitope antibody, a novel site-directed antibody against human acetylcholinesterase
Acta Pharmacol Sin 25 :431

Zhang XM, Liu G, Sun MJ (2004)
Acta Pharmacol Sin 25 :431